GaviLyte-H and Bisacodyl (GAVIS Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the GaviLyte-H and Bisacodyl drug offered from GAVIS Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GAVIS Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-04-21 |
END MARKETING DATE: | 0000-00-00 |
GaviLyte-H and Bisacodyl HUMAN PRESCRIPTION DRUG Details:
Item Description | GaviLyte-H and Bisacodyl from GAVIS Pharmaceuticals, LLC |
LABELER NAME: | GAVIS Pharmaceuticals, LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-04-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43386-071_78f1f6cb-09bd-4c5c-ba86-bfbd66e9576b |
PRODUCT NDC: | 43386-071 |
APPLICATION NUMBER: | ANDA202217 |